Nigral volume loss in prodromal, early, and moderate Parkinson’s disease

The loss of melanized neurons in the substantia nigra pars compacta (SNc) is a hallmark pathology in Parkinson's disease (PD). Melanized neurons in SNc can be visualized in vivo using magnetization transfer (MT) effects. Nigral volume was extracted in data acquired with a MT-prepared gradient echo sequence in 50 controls, 90 non-manifest carriers (46 LRRK2 and 44 GBA1 nonmanifest carriers), 217 prodromal hyposmic participants, 76 participants with rapid eye movement sleep behavior disorder (RBD), 194 de novo PD patients and 26 moderate PD patients from the Parkinson's Progressive Markers Initiative. No difference in nigral volume was seen between controls and LRRK2 and GBA1 non-manifest carriers (F = 0.732; P = 0.483). A significant main effect in group was observed between controls, prodromal hyposmic participants, RBD participants, and overt PD patients (F = 9.882; P < 10<sup>-3</sup>). This study shows that nigral depigmentation can be robustly detected in prodromal and overt PD populations.

Authors

Institutions

Publication Details

Journal
npj Parkinson s Disease
Published
2025-06-21
DOI
https://doi.org/10.1038/s41531-025-00976-3
Citations
3
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
4.17

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nigral volume loss in prodromal, early, and moderate Parkinson’s disease

Xiaoping Hu, Daniel E. Huddleston, Jason Langley, Kristy S Hwang
3 citations
npj Parkinson s Disease
Parkinson's Disease Mechanisms and Treatments
4.17
article

Nigral volume loss in prodromal, early, and moderate Parkinson’s disease

Xiaoping Hu, Daniel E. Huddleston, Jason Langley, Kristy S Hwang
article en
3 citations

Abstract

The loss of melanized neurons in the substantia nigra pars compacta (SNc) is a hallmark pathology in Parkinson's disease (PD). Melanized neurons in SNc can be visualized in vivo using magnetization transfer (MT) effects. Nigral volume was extracted in data acquired with a MT-prepared gradient echo sequence in 50 controls, 90 non-manifest carriers (46 LRRK2 and 44 GBA1 nonmanifest carriers), 217 prodromal hyposmic participants, 76 participants with rapid eye movement sleep behavior disorder (RBD), 194 de novo PD patients and 26 moderate PD patients from the Parkinson's Progressive Markers Initiative. No difference in nigral volume was seen between controls and LRRK2 and GBA1 non-manifest carriers (F = 0.732; P = 0.483). A significant main effect in group was observed between controls, prodromal hyposmic participants, RBD participants, and overt PD patients (F = 9.882; P < 10<sup>-3</sup>). This study shows that nigral depigmentation can be robustly detected in prodromal and overt PD populations.

npj Parkinson s DiseaseVol. 11(1)
University of California, Riverside (US), Emory University (US), University of California, Irvine (US), VA Long Beach Healthcare System (US)
National Institute of Neurological Disorders and Stroke
Good health and well-being
Openalex Percentile: Top 6%
Parkinson's Disease Mechanisms and Treatments
4.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.